Any suggestions for software alternatives to the Roche AVA module for analyzing amplicon variation in 454 data where individuals are identified with tagged primers?
Many thanks, Lisle Gibbs
Many thanks, Lisle Gibbs
-
-
We do highly multiplexed amplicon-based genotyping with 454 and have found AVA inadequate.
Here's how we deconvolute and analyze the tagged sequence data. The key is to split apart the .sff files from the sequencer using Roche's command-line tool called "sfffile" which is available as part of the Roche-454 off-instrument software package. By using the correct arguments and MID-configuration file this will break your data into MID specific .sff files.
Then, we analyze each patient specific sequence data individually. A scriptable assembly software package will allow you to do this in batch. In our case we use Seqman, from DNAstar, to assemble the reads at high identity (99.5 - 100%) and then blast them against a genotyping database. -
How is such a MID configuration file defined?Comment
-
In your 454 software's config directory there will be an MIDConfig.parse file that contains the information in the form:
GSMIDs
{
mid = "MID1", "ACGAGTGCGT", 2;
mid = "MID2", "ACGCTCGACA", 2;
...Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment